No registrations found.
ID
Source
Brief title
Health condition
cervical cancer, HPV clearance
Sponsors and support
Intervention
Outcome measures
Primary outcome
Willingness to use vaginal probiotics
Acceptance treatment duration vaginal probiotics
Inconvenience of use
Secondary outcome
Therapy compliance
Knowledge from patients about their disease
Aversion to HPV infections and invasive treatments for cervical cancer
Background summary
This survey aims to investigate the experience of women with CIN0/1/2 who use vaginal probiotics in order to increase their HPV clearence. It is relevant to acquire knowledge about the willingness of women with CIN0/1/2 to use probiotics to explore if vaginal probiotics can become part of the standard treatment of cervical dysplasia. As part of the study questionnaires will be distributed among women with HPV positivity and cervical dysplasia (LSIL or HSIL), who have not yet undergone major treatment.
Study objective
It is expected that women who experience CIN as an urgent medical condition are more willing to use vaginal probiotics
Study design
Primary and secondary outcomes will be collected with a single questionnaire administered 7 days after use of vaginal probiotics
Inclusion criteria
Women
- with HPV positivity
- who used > 7 days vaginal probiotics
- who can read and write Dutch
- with age 18-65 years old
Exclusion criteria
-undergone invasive treatment of the cervix
-HSIL who need invasive treatment
Design
Recruitment
IPD sharing statement
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL9271 |
| Other | Raad van Bestuur Diakonessenhuis : 21.011 |